Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease-Reference-Cited by-同舟云学术

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

Published:2005-05 Issue:9473 Volume:365 Page:1794-1796
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

van Heel David A,Ghosh Subrata,Butler Matt,Hunt Karen A,Lundberg Anna MC,Ahmad Tariq,McGovern Dermot PB,Onnie Clive,Negoro Kenichi,Goldthorpe Sue,Foxwell Brian MJ,Mathew Christopher G,Forbes Alastair,Jewell Derek P,Playford Raymond J

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease;Hugot;Nature,2001

2. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease;Ogura;Nature,2001

3. CARD15/ NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease;Lesage;Am J Hum Genet,2002

4. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease;Inohara;J Biol Chem,2003

5. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection;Girardin;J Biol Chem,2003

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role and molecular mechanism of NOD2 in chronic non-communicable diseases;Journal of Molecular Medicine;2024-05-14

2. Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease;Scientific Reports;2024-01-09

3. γδ T cells: origin and fate, subsets, diseases and immunotherapy;Signal Transduction and Targeted Therapy;2023-11-22

4. Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease;2023-10-09

5. Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins;Frontiers in Immunology;2023-10-05